Neferine
Cat.No:IN0400 Solarbio
CAS:2292-16-2
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
NF-κB >
NeferineCAS:2292-16-2
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to yellow Solid
Qty:
Size:
CAS | 2292-16-2 |
Name | Neferine |
Molecular Formula | C38H44N2O6 |
Molecular Weight | 624.77 |
Solubility | Soluble in DMSO |
Purity | HPLC≥98% |
Appearance | White to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD01707128 |
SMILES | OC1=CC=C(C[C@@H]2N(C)CCC3=C2C=C(OC)C(OC)=C3)C=C1OC4=CC5=C(C=C4OC)CCN(C)[C@@H]5CC6=CC=C(OC)C=C6 |
Target Point | NF-kB |
Passage | NF-κB |
Background | Neferine, a bisbenzylisoquinoline alkaloid, potently inhibits NF-κB activation. |
Biological Activity | Neferine 是一种双苄基异喹啉类生物碱。Neferine 强效抑制 NF-κB 激活。 |
In Vitro | Neferine减少高葡萄糖诱导的胶原蛋白生成并抑制心脏成纤维细胞中TGF-β1-Smad,ERK和p38 MAPK信号传导的激活。在具有不同浓度的Neferine(1,2或5μM)的HG培养基中培养心脏成纤维细胞(CF)。 CCK-8测定在不同时间点(24,48和72小时)进行。与正常葡萄糖(NG)和渗透控制(OC)处理相比,高葡萄糖(30mM)处理以时间依赖性方式显著增加CFs的增殖(P <0.05)。与媒介物处理相比,通过2或5μM的Neferine处理,高葡萄糖(HG)诱导的CF增殖显著减弱。然而,1μM的Neferine不抑制HG诱导的CF增殖。因此,在剩余的实验中使用2和5μM的甲基莲心碱[2]。Neferine down调节缺氧诱导的NF-κBp65核转位和COX-2表达[1]。 |
In Vivo | 低剂量(60 mg/kg /天灌胃)和高剂量(120 mg/kg /天灌胃)的甲基莲心碱治疗可降低高血糖诱导的I,III和TGF-β1蛋白表达增加[2] 。 |
Cell Experiment | 从新生小鼠心室组织分离心脏成纤维细胞(CF)。在无血清培养基中饥饿24小时后,将CFs在含有5.6mM葡萄糖(正常葡萄糖; NG),30mM D-葡萄糖(HG),30mM D-葡萄糖加1μMNeferine,30mM D-的DMEM中孵育。葡萄糖加2μMNeferine,30mM D-葡萄糖加5μMNeferine,和5.6mM葡萄糖加27.5mM甘露糖。在24小时,48小时和72小时收获细胞。用Cell Counting Kit-8(CCK-8)和Cell-LightTM EdU测定[2]测量细胞增殖。 |
Animal Experiment | 小鼠[2]使用8周龄的C57BL/6J雄性小鼠。通过腹膜内注射溶解在柠檬酸盐缓冲液(pH4.5)中的链脲佐菌素以60mg/kg体重诱导糖尿病,连续5天。对照小鼠仅注射柠檬酸盐缓冲液。用Accu-Check Active血糖仪检测小鼠尾血中的全血葡萄糖。血糖浓度高于18mM的小鼠被认为是糖尿病动物并用于本研究。将动物随机分成四组,每组八只动物。糖尿病小鼠分为三组:第1组,糖尿病对照组(DM);第2组,以60mg/kg /天的剂量接受甲基莲心碱(DM-NL);和组3,其以120mg/kg /天(DM-NH)的剂量接受Neferine。每天通过胃内灌胃给予Neferine两次,持续12周。通过管饲法向正常和DM对照组施用等量的正常钠。在12周治疗结束时将小鼠麻醉并处死[2]。 |
Data Literature Source | [1]. Baskaran R,et al. Neferine prevents NF-κB translocation and protects muscle cells from oxidative stress and apoptosis induced by hypoxia. Biofactors. 2016 Jul 8;42(4):407-17. [2]. Liu X,et al. Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice. Oncotarget. 2016 Sep 20;7(38):61703-61715. |
Unit | Bottle |
Specification | 5mg 10mM*1mL in DMSO 10mg 20mg |
Neferine 是一种双苄基异喹啉类生物碱,能够强效抑制 NF-κB 激活。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.